NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/07/2023
Back to search
Official data from USPTO
MANDELL'S CLINICAL PHARMACY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
11/07/2023
Trademark type
Combined
Nice classes
35, 44
Filing date
09/05/2022
Registration date
11/07/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/07/2023
Last transaction
11/07/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2022-01-00
First use in commerce
2022-01-00
Drawing code
3
Owner type
03
Owner location
Somerset, NJ, US
Examiner
EMILO, LORI ANNE
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of blue oval, with a yellow line border and then two blue line borders. The inside of the oval has a sun with a blue center and yellow rays. Under the sun are the words "MANDELL'S" in white stylized lettering and a blue border, and "CLINICAL PHARMACY" below in smaller white plain block print.
Holders and representatives
Holders
Malanda Inc.
Representatives
Julianne Abelman WOMBLE BOND DICKINSON (US) LLP
Technical classification
Nice Classes
Class 35Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Pharmaceutical servicesprocessing telephone prescription orders in retail pharmacies
Class 44
Dispensing of pharmaceuticals; Pharmaceutical consultation; Pharmaceutical advice; Pharmaceutical compounding services; Providing information relating to prophylactic and therapeutic properties of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/07/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/22/2023
PUBO
PUBLISHED FOR OPPOSITION
08/22/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/02/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/19/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/14/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/14/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/14/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/22/2023
GNRT
NON-FINAL ACTION E-MAILED
06/22/2023
CNRT
NON-FINAL ACTION WRITTEN
06/22/2023
DOCK
ASSIGNED TO EXAMINER
06/20/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/23/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/22/2022
NWAP
NEW APPLICATION ENTERED
09/08/2022
Continuous trademark protection
Get notified about every new filing that threatens MANDELL'S CLINICAL PHARMACY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.